Fanucci Marsha is a director of Alnylam Pharmaceuticals Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Syros Pharmaceuticals, Inc.
7 Jun 24
4
Syros Pharmaceuticals, Inc.
2 Jun 23
4
ALNYLAM PHARMACEUTICALS, INC.
19 May 23
4
ALNYLAM PHARMACEUTICALS, INC.
27 Feb 23
4
Forma Therapeutics Holdings, Inc.
14 Oct 22
4
Syros Pharmaceuticals, Inc.
19 Sep 22
4
Cyclerion Therapeutics, Inc.
16 Jun 22
4
Forma Therapeutics Holdings, Inc.
9 Jun 22
4
Syros Pharmaceuticals, Inc.
2 Jun 22
4
ALNYLAM PHARMACEUTICALS, INC.
20 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 24 | SYRS Syros Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 16,000 |
5 Jun 24 | SYRS Syros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 5.3 | 6,000 | 31.80 k | 6,000 |
1 Jun 23 | SYRS Syros Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 12,000 |
1 Jun 23 | SYRS Syros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.7 | 6,000 | 22.20 k | 6,000 |
18 May 23 | ALNY Alnylam Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 189.87 | 3,454 | 655.81 k | 3,454 |
23 Feb 23 | ALNY Alnylam Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 136 | 0.00 | 136 |
23 Feb 23 | ALNY Alnylam Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 136 | 0.00 | 0 |